The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Impact of apoE genotype on oxidative stress, inflammation and disease risk
Abstract
Although in developing countries an apolipoprotein E4 (apoE4) genotype may offer an evolutionary advantage, as it has been shown to offer protection against certain infectious disease, in Westernised societies it is associated with increased morbidity and mortality, and represents a significant risk factor for cardiovascular disease, late‐onset Alzheimer's disease and other chronic disorders. ApoE is an important modulator of many stages of lipoprotein metabolism and traditionally the increased risk was attributed to higher lipid levels in E4 carriers. However, more recent evidence demonstrates the multifunctional nature of the apoE protein and the fact that the impact of genotype on disease risk may be in large part due to an impact on oxidative status or the immunomodulatory/anti‐inflammatory properties of apoE. An increasing number of studies in cell lines, targeted replacement rodents and human volunteers indicate higher oxidative stress and a more pro‐inflammatory state associated with the ε4 allele. The impact of genotype on the antioxidant and immunomodulatory/anti‐inflammatory properties of apoE is the focus of the current review. Furthermore, current information on the impact of environment (diet, exercise, smoking status, alcohol) on apoE genotype‐phenotype associations are discussed with a view to identifying particular lifestyle strategies that could be adapted to counteract the ‘at‐risk’ E4 genotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857
Apolipoprotein E polymorphism and Alzheimer's disease
Poirier, J., Bertrand, P., Poirier, J., Kogan, S., Gauthier, S., Poirier, J., Gauthier, S., Davignon, J., Bouthillier, D., & Davignon, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91705-q · Cited by 1,108
Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52510-8 · Cited by 777
Human apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741
Miyata, M., & Smith, J. D. (1996) · Nature Genetics · doi:10.1038/ng0996-55 · Cited by 735
Association of apolipoprotein E polymorphism with outcome after head injury
Teasdale, G. M., Nicoll, J. A., Murray, G., & Fiddes, M. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04318-3 · Cited by 694
Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34954-8 · Cited by 673
Apolipoprotein E in animal models of CNS injury and in alzheimer's disease
Poirier, J. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90156-2 · Cited by 639
Apolipoprotein E structure: insights into function
Hatters, D. M., Peters-Libeu, C. A., & Weisgraber, K. H. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.06.008 · Cited by 583 · cited 2×
“This is thought to impact on the chemical and thermal stability of the protein and in the formation of folding intermediates, with apoE2 showing the greatest stability and least formation of intermediates, while apoE4 shows the opposite properties, forming a typical molten globule configuration [20].”
Apolipoprotein E Alleles and Risk of Coronary Disease: A Meta-analysis
Wilson, P. W. F., Schaefer, E. J., Larson, M. G., & Ordovas, J. M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.10.1250 · Cited by 539
Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease
Song, Y., Stampfer, M. J., & Liu, S. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-2-200407200-00013 · Cited by 528
Praticò, D., Tangirala, R. K., Rader, D. J., Rokach, J., & FitzGerald, G. A. (1998) · Nature Medicine · doi:10.1038/2685 · Cited by 501
Apolipoprotein E-ε4 genotype predicts a poor outcome in survivors of traumatic brain injury
Friedman, G., Froom, P., Sazbon, L., Grinblatt, I., Shochina, M., Tsenter, J., Babaey, S., Yehuda, A. B., & Groswasser, Z. (1999) · Neurology · doi:10.1212/wnl.52.2.244 · Cited by 440
Lynch, J. R., Tang, W., Wang, H., Vitek, M. P., Bennett, E. R., Sullivan, P. M., Warner, D. S., & Laskowitz, D. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306923200 · Cited by 394
Anttila, T., Helkala, E.-L., Viitanen, M., Kåreholt, I., Fratiglioni, L., Winblad, B., Soininen, H., Tuomilehto, J., Nissinen, A., & Kivipelto, M. (2004) · BMJ · doi:10.1136/bmj.38181.418958.be · Cited by 323
Dong, L. M., Wilson, C., Wardell, M. R., Simmons, T., Mahley, R. W., Weisgraber, K. H., & Agard, D. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31797-0 · Cited by 320
Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study
Lahoz, C., Schaefer, E. J., Cupples, L. A., Wilson, P. W. F., Levy, D., Osgood, D., Parpos, S., Pedro-Botet, J., Daly, J. A., & Ordovas, J. M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00570-0 · Cited by 317
Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E.
Basu, S. K., Brown, M. S., Ho, Y. K., Havel, R. J., & Goldstein, J. L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7545 · Cited by 300
Bellosta, S., Mahley, R. W., Sanan, D. A., Murata, J., Newland, D. L., Taylor, J. M., & Pitas, R. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118271 · Cited by 284
Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study
Humphries, S. E., Talmud, P. J., Hawe, E., Bolla, M., Day, I. N., & Miller, G. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05330-2 · Cited by 252
HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy
Corder, E. H., Robertson, K., Lannfelt, L., Bogdanovic, N., Eggertsen, G., Wilkins, J., & Hall, C. (1998) · Nature Medicine · doi:10.1038/2677 · Cited by 249
Ramassamy, C., Averill, D., Beffert, U., Bastianetto, S., Theroux, L., Lussier-Cacan, S., Cohn, J. S., Christen, Y., Davignon, J., Quirion, R., et al. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00102-1 · Cited by 241
C-reactive protein in atherosclerosis: A causal factor?
PAFFEN, E., & DEMAAT, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.03.004 · Cited by 226
TLR Signaling: An Emerging Bridge from Innate Immunity to Atherogenesis
Michelsen, K. S., Doherty, T. M., Shah, P. K., & Arditi, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.5901 · Cited by 212
Predictors of cognitive decline after cardiac operation
Newman, M. F., Croughwell, N. D., Blumenthal, J. A., Lowry, E., White, W. D., Spillane, W., Davis, R. D., Glower, D. D., Smith, L. R., Mahanna, E. P., et al. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00076-w · Cited by 210
de Bont, N., Netea, M. G., Demacker, P. N. M., Verschueren, I., Kullberg, B. J., van Dijk, K. W., van der Meer, J. W. M., & Stalenhoef, A. F. H. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32147-7 · Cited by 210
Apolipoprotein E Inhibits Platelet Aggregation through the L-Arginine:Nitric Oxide Pathway
Riddell, D. R., Graham, A., & Owen, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.89 · Cited by 209
Ruiz, J., Kouiavskaia, D., Migliorini, M., Robinson, S., Saenko, E. L., Gorlatova, N., Li, D., Lawrence, D., Hyman, B. T., Weisgraber, K. H., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500114-jlr200 · Cited by 204
Khachigian, L. M., Anderson, K. R., Halnon, N. J., Gimbrone, M. A., Resnick, N., & Collins, T. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.2280 · Cited by 202
Oxidative Insults Are Associated with Apolipoprotein E Genotype in Alzheimer's Disease Brain
Ramassamy, C., Averill, D., Beffert, U., Theroux, L., Lussier-Cacan, S., Cohn, J. S., Christen, Y., Schoofs, A., Davignon, J., & Poirier, J. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0273 · Cited by 195
Roselaar, S. E., & Daugherty, A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32160-x · Cited by 193
Lynch, J. R., Morgan, D., Mance, J., Matthew, W. D., & Laskowitz, D. T. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00459-8 · Cited by 187
Apolipoprotein E Protects Against Bacterial Lipopolysaccharide-induced Lethality
Van Oosten, M., Rensen, P. C. N., Van Amersfoort, E. S., Van Eck, M., Van Dam, A.-M., Brevé, J. J. P., Vogel, T., Panet, A., Van Berkel, T. J. C., & Kuiper, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009915200 · Cited by 186
Apolipoprotein E-ε4 protects against severe liver disease caused by hepatitis C virus
Wozniak, M. A., Itzhaki, R. F., Faragher, B. E., James, M. W., Ryder, S. D., & Irving, W. L. (2002) · Hepatology · doi:10.1053/jhep.2002.34745 · Cited by 181
Innerarity, T. L., Weisgraber, K. H., Arnold, K. S., Rall, S. C., & Mahley, R. W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39866-6 · Cited by 179
A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity
Guo, L., LaDu, M. J., & Van Eldik, L. J. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:205 · Cited by 175
Apolipoprotein E suppresses glial cell secretion of TNFα
Laskowitz, D. T., Goel, S., Bennett, E. R., & Matthew, W. D. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00021-0 · Cited by 175
Increased Plasma and Lipoprotein Lipid Peroxidation in apo E-Deficient Mice
Hayek, T., Oiknine, J., Brook, J. G., & Aviram, M. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1883 · Cited by 171
Lipoproteins in the Central Nervous System
LADU, M. J., REARDON, C., VAN ELDIK, L., FAGAN, A. M., BU, G., HOLTZMAN, D., & GETZ, G. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06365.x · Cited by 167
Apolipoprotein E4 enhances brain inflammation by modulation of the NF-κB signaling cascade
Ophir, G., Amariglio, N., Jacob-Hirsch, J., Elkon, R., Rechavi, G., & Michaelson, D. M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.002 · Cited by 166
Microglial Activation in Alzheimer Disease: Association with APOE Genotype
Egensperger, R., Kösel, S., von Eitzen, U., & Graeber, M. B. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00166.x · Cited by 164
Lauderback, C. M., Kański, J., Hackett, J. M., Maeda, N., Kindy, M. S., & Butterfield, D. A. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03228-0 · Cited by 149
APOE4 Protects the Cognitive Development in Children with Heavy Diarrhea Burdens in Northeast Brazil
Oriá, R. B., Patrick, P. D., Zhang, H., Lorntz, B., Costa, C. M. D. C., Brito, G. A. D. C., Barrett, L. J., Lima, A. Â. M., & Guerrant, R. L. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000148719.82468.ca · Cited by 148
Pepe, M. G., & Curtiss, L. K. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.10.3716 · Cited by 147
Quantitation of apolipoprotein E mRNA in the liver and peripheral tissues of nonhuman primates.
Newman, T. C., Dawson, P. A., Rudel, L. L., & Williams, D. L. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89575-8 · Cited by 144
Pedersen, W. A., Chan, S. L., & Mattson, M. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741426.x · Cited by 144
Minihane, A. M., Jofre‐Monseny, L., Olano-Martin, E., & Rimbach, G. H. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005435 · Cited by 139
Self-citationShimano, H., Ohsuga, J.-I., Shimada, M., Namba, Y., Gotoda, T., Harada, K., Katsuki, M., Yazaki, Y., & Yamada, N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117687 · Cited by 134
Kelly, M. E., Clay, M. A., Mistry, M. J., Hsieh-Li, H.-M., & Harmony, J. A. K. (1994) · Cellular Immunology · doi:10.1006/cimm.1994.1302 · Cited by 131
Corella, D., Tucker, K. L., Lahoz, C., Coltell, Ó., Cupples, L. A., Wilson, P. W. F., Schaefer, E. J., & Ordovás, J. M. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.4.736 · Cited by 131
Apolipoprotein E modulates immune activation by acting on the antigen‐presenting cell
Tenger, C., & Zhou, X. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01665.x · Cited by 129
Cognitive Performance in Older Women Relative to ApoE-ε4 Genotype and Aerobic Fitness
ETNIER, J. L., CASELLI, R. J., REIMAN, E. M., ALEXANDER, G. E., SIBLEY, B. A., TESSIER, D., & MCLEMORE, E. C. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000239399.85955.5e · Cited by 124
Guo, Z., Mitchell-Raymundo, F., Yang, H., Ikeno, Y., Nelson, J., Diaz, V., Richardson, A., & Reddick, R. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00008-8 · Cited by 121 · cited 1×
“In apoE null mice, caloric restriction could retard atherosclerosis through a mechanism that was independent of plasma cholesterol levels [100].”
Reduction of Isoprostanes and Regression of Advanced Atherosclerosis by Apolipoprotein E
Tangirala, R. K., Praticò, D., FitzGerald, G. A., Chun, S. H., Tsukamoto, K., Maugeais, C., Usher, D. C., Puré, E., & Rader, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003324200 · Cited by 120
Maezawa, I., Nivison, M. P., Montine, K. S., Maeda, N., & Montine, T. J. (2006) · The FASEB Journal · doi:10.1096/fj.05-5423fje · Cited by 118
COLTON, C., BROWN, C., COOK, D., NEEDHAM, L., XU, Q., CZAPIGA, M., SAUNDERS, A., SCHMECHEL, D., RASHEED, K., & VITEK, M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00016-7 · Cited by 108
Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression
Jofre‐Monseny, L., Łoboda, A., Wagner, A. E., Huebbe, P., Boesch, C., Józkowicz, A., Minihane, A. M., Dulak, J., & Rimbach, G. H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.150 · Cited by 108
Self-citationStannard, A. K., Riddell, D. R., Sacre, S. M., Tagalakis, A. D., Langer, C., von Eckardstein, A., Cullen, P., Athanasopoulos, T., Dickson, G., & Owen, J. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104812200 · Cited by 103
Influence of Apolipoprotein E, Smoking, and Alcohol Intake on Carotid Atherosclerosis
Djoussé, L., Myers, R. H., Province, M. A., Hunt, S. C., Eckfeldt, J. H., Evans, G. W., Peacock, J. M., & Ellison, R. C. (2002) · Stroke · doi:10.1161/01.str.0000014325.54063.1a · Cited by 99
Thakkinstian, A., Bowe, S. J., McEvoy, M., Smith, W. T., & Attia, J. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj279 · Cited by 95
Gene–environment interaction and its impact on coronary heart disease risk
Talmud, P. J. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.01.008 · Cited by 94
Campalani, E., Allen, M. H., Fairhurst, D. A., Young, H. S., Mendonça, C. O., Burden, A. D., Griffiths, C. E. M., Crook, M. A., Barker, J. N., & Smith, C. H. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06950.x · Cited by 89
März, W., Scharnagl, H., Hoffmann, M. M., Boehm, B. O., & Winkelmann, B. R. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.08.024 · Cited by 89
Lewis, S. J., & Brunner, E. J. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh214 · Cited by 85
Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice
Maezawa, I., Maeda, N., Montine, T. J., & Montine, K. S. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-10 · Cited by 83
Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids
Jolivalt, C. G., Leininger‐Muller, B., Bertrand, P., Herber, R., Christen, Y., & Siest, G. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00232-4 · Cited by 82
Talmud, P. J., Stephens, J. W., Hawe, E., Demissie, S., Cupples, L. A., Hurel, S. J., Humphries, S. E., & Ordovás, J. M. (2005) · Annals of Human Genetics · doi:10.1111/j.1529-8817.2005.00205.x · Cited by 78
Corella, D., Guillén, M., Saacuteiz, C., Portoleacutes, O., Martínez‐Sabater, A., Cortina, S. H. M., Folch, J., Gonz[aacute]lez, J. I., & Ordovás, J. M. (2001) · Metabolism · doi:10.1053/meta.2001.24867 · Cited by 77
Oriá, R. B., Patrick, P. D., Blackman, J. A., Lima, A. Â. M., & Guerrant, R. L. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.09.036 · Cited by 77
Economou-Petersen, E., Aessopos, A., Kladi, A., Flevari, P., Karabatsos, F., Fragodimitri, C., Nicolaidis, P., Vrettou, H., Vassilopoulos, D., Karagiorga‐Lagana, M., et al. (1998) · Blood · doi:10.1182/blood.v92.9.3455 · Cited by 75
Apolipoprotein E allele–dependent antioxidant activity in brains with Alzheimer’s disease
Tamaoka, A., Miyatake, F., Matsuno, S., Ishii, K., Nagase, S., Sahara, N., Ono, S., Mori, H., Wakabayashi, K., Tsuji, S., et al. (2000) · Neurology · doi:10.1212/wnl.54.12.2319 · Cited by 70
Apolipoprotein E and mimetic peptide initiate a calcium-dependent signaling response in macrophages
Misra, U. K., Adlakha, C. L., Gawdi, G., McMillian, M., Pizzo, S. V., & Laskowitz, D. T. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.4.677 · Cited by 66
Judson, R., Brain, C. W., Dain, B., Windemuth, A., Ruaño, G., & Reed, C. R. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.012 · Cited by 65
The Receptor Binding Domain of Apolipoprotein E Is Responsible for Its Antioxidant Activity
Pham, T., Kodvawala, A., & Hui, D. Y. (2005) · Biochemistry · doi:10.1021/bi0472696 · Cited by 60
Physiological Factors Influencing Vitamin E Biokinetics
Lodge, J. K., Hall, W. L., Jeanes, Y., & Proteggente, A. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1331.006 · Cited by 58
Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A/G1B boundary
Mistry, M. J., Clay, M. A., Kelly, M. E., Steiner, M. A., & Harmony, J. A. K. (1995) · Cellular Immunology · doi:10.1016/0008-8749(95)80004-3 · Cited by 58
Apolipoprotein‐E Allele‐Specific Regulation of Nitric Oxide Production
Colton, C. A., Brown, C. M., Czapiga, M., & Vitek, M. P. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04070.x · Cited by 52
Tziakas, D. N., Chalikias, G. K., Antonoglou, C., Veletza, S. V., Tentes, I. K., Kortsaris, A. X., Hatseras, D., & Kaski, J. C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.032 · Cited by 51
Differential effects of apolipoprotein E3 and E4 on markers of oxidative status in macrophages
Jofre‐Monseny, L., de Pascual‐Teresa, S., Plonka, E., Huebbe, P., Boesch, C., Minihane, A. M., & Rimbach, G. H. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507669219 · Cited by 49
Self-citationInfluence of apolipoprotein E genotype on blood redox status of Alzheimer's disease patients.
Fernandes, M. A. S., Proenca, M. T., Nogueira, A. J. A., Grazina, M. M., Oliveira, L. M. V., Fernandes, A. I., Santiago, B., Santana, I. J., & Oliveira, C. R. (1999) · International Journal of Molecular Medicine · doi:10.3892/ijmm.4.2.179 · Cited by 48
The association between apolipoprotein E and multiple sclerosis
Pinholt, M., Frederiksen, J. L., & Christiansen, M. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01360.x · Cited by 47
Tsoi, L.-M., Wong, K., Liu, Y.-M., & Ho, Y.-Y. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.01.019 · Cited by 46
Associations between apolipoprotein E genotype and circulating F2‐isoprostane levels in humans
Dietrich, M., Hu, Y., Block, G., Olano-Martin, E., Packer, L., Morrow, J. D., Hudes, M. L., Abdukeyum, G., Rimbach, G. H., & Minihane, A. M. (2005) · Lipids · doi:10.1007/s11745-006-1390-4 · Cited by 44
Self-citationStöhr, J., Schindler, G., Rothe, G., & Schmitz, G. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.9.1424 · Cited by 42
The secretion of apolipoprotein E by human monocytederived macrophages
Kayden, H. J., Maschio, F. A., & Traber, M. G. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90704-0 · Cited by 41
Kitagawa, K., Matsumoto, M., Kuwabara, K., 高沢健一郎, Tanaka, S., Sasaki, T., Matsushita, K., Ohtsuki, T., Yanagihara, T., & Hori, M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10209 · Cited by 41
Yao, J., Petanceska, S. S., Montine, T. J., Holtzman, D. M., Schmidt, S. D., Parker, C. A., Callahan, M. J., Lipinski, W. J., Bisgaier, C. L., Turner, B. A., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02532.x · Cited by 41
Drabe, N., ZundZünd, G., GrunenfelderGrünenfelder, J., Sprenger, M., Hoerstrup, S. P., Bestmann, L., Maly, F. E., & Turina, M. I. (2001) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(01)00842-9 · Cited by 41
Apolipoprotein E polymorphism and C-reactive protein in dyslipidemic middle-aged men
Mänttäri, M., Manninen, V., Palosuo, T., & Ehnholm, C. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00480-4 · Cited by 38
The intracellular fate of apolipoprotein E is tau dependent and apoe allelespecific
Lovestone, S., Anderton, B. H., Hartley, C., Jensen, T. G., & Jørgensen, A. L. (1996) · Neuroreport · doi:10.1097/00001756-199604100-00010 · Cited by 35
Zeleny, M., Swertfeger, D. K., Weisgraber, K. H., & Hui, D. Y. (2002) · Biochemistry · doi:10.1021/bi026202k · Cited by 34
Djoussé, L., Pankow, J. S., Arnett, D. K., Eckfeldt, J. H., Myers, R. H., & Ellison, R. C. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1639 · Cited by 34
Secreted apolipoprotein E reduces macrophage‐mediated LDL oxidation in an isoform‐dependent way
Mabile, L., Lefèbvre, C., Lavigne, J., Boulet, L., Davignon, J., Lussier‐Cacan, S., & Bernier, L. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10697 · Cited by 32
Relationship between oxidative stress and apoE phenotype in Alzheimer's disease
Ihara, Y., Hayabara, T., Sasaki, K., Kawada, R., Nakashima, Y., & Kuroda, S. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.102006346.x · Cited by 29
Influence of apolipoprotein E polymorphism on plasma vitamin A and vitamin E levels
Gómez‐Coronado, D., Bueno, A. E., Álvarez, J. J., Ortega, H., Olmos, J. M., Castro, M., Sastre, A., Herrera, E., & Lasunción, M. A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00983.x · Cited by 27
Tsuda, M., Sanada, M., Nakagawa, H., Kodama, I., Sakashita, T., & Ohama, K. (2001) · Maturitas · doi:10.1016/s0378-5122(01)00171-2 · Cited by 23
Dietary vitamin C down-regulates inflammatory gene expression in apoE4 smokers
Majewicz, J., Rimbach, G. H., Proteggente, A. R., Lodge, J. K., Kraemer, K., & Minihane, A. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.029 · Cited by 21
Self-citationKahri, J., Soro‐Paavonen, A., Ehnholm, C., & Taskinen, M. (2006) · Mediators of Inflammation · doi:10.1155/mi/2006/12587 · Cited by 21
Apolipoprotein E and First-ever Ischaemic Stroke in Greek Hospitalized Patients
Giassakis, G., Veletza, S. V., Παπάνας, Ν., Heliopoulos, I., & Piperidou, H. (2007) · Journal of International Medical Research · doi:10.1177/147323000703500114 · Cited by 14
The value of genotyping for apolipoprotein E alleles in relation to vitamin E supplementation
Peroutka, S. J., & Dreon, D. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00813-x · Cited by 13
Apolipoprotein E ε4 offers protection against age-related macular degeneration
Friedman, D. A., Lukiw, W. J., & Hill, J. M. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.09.049 · Cited by 8
Tsuda, M., Sanada, M., Higashi, Y., Hara, Y., Kodama, I., Chayama, K., Yoshizumi, M., & Ohama, K. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02145.x · Cited by 5
Cited by
Liu, L., MacKenzie, K. R., Putluri, N., Maletić-Savatić, M., & Bellen, H. J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.024 · Cited by 556
Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall
Getz, G. S., & Reardon, C. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800058-jlr200 · Cited by 319
Fish, docosahexaenoic acid and Alzheimer’s disease
Cunnane, S. C., Plourde, M., Pifferi, F., Bégin, M., Féart, C., & Barberger-Gateau, P. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.04.001 · Cited by 317
Omega-3 fatty acids and dementia
Cole, G. M., Ma, Q.-L., & Frautschy, S. A. (2009) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.05.015 · Cited by 269
The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D)
Raison, C. L., & Miller, A. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.2 · Cited by 253
Metadata
- Authors
- Jofre‐Monseny, L., Minihane, A., & Rimbach, G.
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2008-01
- Volume
- 52
- Issue
- 1
- Pages
- 131-145
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W2128526521
- Cited by
- 318
- References
- 104
- FWCI
- 25.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.